Acceleron Financial Statements From 2010 to 2024
Acceleron Pharma financial statements provide useful quarterly and yearly information to potential Acceleron Pharma investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Acceleron Pharma financial statements helps investors assess Acceleron Pharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Acceleron Pharma's valuation are summarized below:Acceleron Pharma does not presently have any fundamental signals for analysis.
This module can also supplement various Acceleron Pharma Technical models . Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Check Acceleron Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acceleron main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Acceleron financial statements analysis is a perfect complement when working with Acceleron Pharma Valuation or Volatility modules.
Acceleron |
Acceleron Pharma Company Shares Outstanding Analysis
Acceleron Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Acceleron Pharma Shares Outstanding | 60.7 M |
Most of Acceleron Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acceleron Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Acceleron Pharma has 60.7 M of shares currently outstending. This is 66.38% lower than that of the Healthcare sector and 43.19% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 89.38% higher than that of the company.
Acceleron Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Acceleron Pharma's current stock value. Our valuation model uses many indicators to compare Acceleron Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acceleron Pharma competition to find correlations between indicators driving Acceleron Pharma's intrinsic value. More Info.Acceleron Pharma is rated first in return on equity category among related companies. It is rated first in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acceleron Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acceleron Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Acceleron Pharma's earnings, one of the primary drivers of an investment's value.Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acceleron Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acceleron Pharma's short interest history, or implied volatility extrapolated from Acceleron Pharma options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Acceleron Stock
If you are still planning to invest in Acceleron Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acceleron Pharma's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |